European Archives - Page 1175 of 1218 - European Medical Journal

EMJ

ASH 2014: Phase II study of lenalidomide plus rituximab for mantle cell lymphoma (Part 2)

Dr Jia Ruan (Weill Cornell Medical College, New York, NY) at the 2014 American Society of Hematology (ASH) Annual Meeting discusses the clinical relevance…

EMJ

Prof John Gribben and Prof Marek Trněný at ASH 2014: Mantle cell lymphoma advances (Part 1)

At the 2014 American Society of Hematology (ASH) Annual Meeting, Prof John Gribben (Barts Cancer Institute, London, UK) and Prof Marek Trněný (Charles…

EMJ

ASH 2014: New therapies for mantle cell lymphoma

Prof Umberto Vitolo (Città della Salute e della Scienza di Torino, Turin, Italy) at the 2014 American Society of Hematology (ASH) Annual Meeting…

EMJ

Hospira Launches First Biosimilar Monoclonal Antibody (mAb) InflectraTM (Infliximab) in Major European Markets

LAKE FOREST, Ill., February 16, 2015 — Hospira, Inc. (NYSE: HSP), a world leader in the development of biosimilar therapies, today announced the launch…

EMJ

Can the Menstrual Cycle Influence Cigarette Craving?

WOMEN looking to give up smoking may need to consider the potential impact of their menstrual cycle on their ability to resist nicotine craving.

EMJ

Innovative Procedure to Make Placenta Accreta-Complicated Births Safer

TREATMENT involving the use of balloons could potentially save the lives of women who have a pregnancy complication called placenta accreta (PA)…

EMJ

Human Primordial Germ Cells to Pave the Way in Fertility Treatments

ADVANCES in treatments for fertility problems and age-related diseases are set to take place following a new breakthrough by researchers.

EMJ

The Big Implications of Looking after Your ‘Little Guys’

INFERTILITY due to poor semen quality may be associated with a number of specific medical conditions, including hypertension, peripheral artery disease…

EMJ

The role of nurses for supporting patients with myeloma

At the United Kingdom Oncology Nursing Society (UKONS) Annual Conference 2015, Monica Morris, Healthcare Professional Programme Manager, Myeloma UK…

Predictive Value of MRI for Clinical Outcomes

The meeting outlined the evidence that the use of magnetic resonance imaging (MRI) markers as surrogate endpoints in clinical trials of…